30
Participants
Start Date
November 30, 2014
Primary Completion Date
November 30, 2015
Study Completion Date
November 30, 2015
rVSVΔ-ZEBOV-GP
single dose of rVSVΔ-ZEBOV-GP (3x10\^6 pfu, 2x10\^7 pfu or 3x10\^5)
CTC North GmbH & Co. KG, Hamburg
Collaborators (2)
German Center for Infection Research
OTHER
Philipps University Marburg
OTHER
World Health Organization
OTHER
Clinical Trial Center North
UNKNOWN
University Hospital, Geneva
OTHER
Albert Schweitzer Hospital
OTHER
Institute of Tropical Medicine, University of Tuebingen
OTHER
Wellcome Trust
OTHER
KEMRI-Wellcome Trust Collaborative Research Program
OTHER
Universitätsklinikum Hamburg-Eppendorf
OTHER